Results 201 to 210 of about 33,398 (247)

Modafinil-associated psychosis: a systematic review of case characteristics and management strategies. [PDF]

Ther Adv Psychopharmacol
Sato Y, Sakuma A, Tomita H.
europepmc   +1 more source

Shared and Distinct Time-Space Experiences Along the Psychotic-Affective Continuum. [PDF]

Schizophr Bull
Lechner S, Arantes-Gonçalves F, Fritze S, Daub J, Brandt GA, Hirjak D, Konicar L, Northoff G.   +7 more
europepmc   +1 more source

Psychotic Spectrum Symptoms in Adults with Autism Spectrum Disorder and in Their First-Degree Relatives. [PDF]

Brain Sci
Nardi B, Parri F, Pini S, Giovannoni F, Pronestì C, Tarantino S, Massimetti G, Cremone IM, Dell'Osso L, Carpita B.   +9 more
europepmc   +1 more source

Parkinson's disease beyond motor symptoms: a review of the validity and limitations of current classification of non-motor symptoms. [PDF]

Front Psychiatry
Makhani A, Mestre TA, Abe AM.
europepmc   +1 more source

Interplay of Subjective Symptoms Across the Stages of the Schizophrenia Spectrum. [PDF]

Psychiatry Investig
Park HY, Bang M, An SK.
europepmc   +1 more source

Are psychosis polygenic risk scores ready for youth mental healthcare? A qualitative interview study of stakeholders’ perspectives

Burnett L, Carr E, Sanderson S.
europepmc   +1 more source

Evidence for Shared Genetic Risk Between Methamphetamine-Induced Psychosis and Schizophrenia [PDF]

Neuropsychopharmacology, 2013
Methamphetamine (METH) use can provoke psychotic reactions requiring immediate treatment, namely METH-induced psychosis. Although the distinction between METH-induced and primary psychosis is important for understanding their clinical courses, we do not have clear diagnostic procedure by their symptoms.
Masashi Ikeda, Branko Aleksic, Ryota Hashimoto   +2 more
exaly   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Team-Based Shared Formulation for Psychosis

2022
Andrew Fox, Alan Meaden
exaly   +2 more sources